The Latest Cardiac and Vascular News
IRVINE, Calif.–(BUSINESS WIRE)–Endologix, Inc. (Nasdaq:ELGX), a developer and marketer of innovative treatments for aortic disorders, announced 1-year results from the LUCY (Evaluation of FemaLes who are Underrepresented Candidates for Abdominal Aortic AneurYsm Repair) registry as reported on Saturday, June 23rd at the 2018 Society for Vascular Surgery Annual Meeting. The LUCY study […]
SOUTHLAKE, Texas–(BUSINESS WIRE)–HeartSciences, an innovative medical device company, is proud to announce its participation as an exhibitor at the upcoming 2018 International Congress on Electrocardiology (ICE), which will be held in Makuhari Messe, Chiba City, Japan, June 28-30, 2018. ICE2018 will be the joint meeting of the 45th Congress of […]
VANCOUVER, British Columbia, June 25, 2018 (GLOBE NEWSWIRE) — Novoheart (“Novoheart” or the “Company”) (TSX-V:NVH) (FWB:3NH) is pleased to announce a presentation was delivered on June 22nd, 2018, entitled “Modeling Cardiac Dysfunction of Friedreich’s Ataxia Using Ventricular Sheets, Tissues and Chambers Engineered from Human Pluripotent Stem Cells,” at the Annual Meeting of […]
NEW YORK, June 25, 2018 (GLOBE NEWSWIRE) — Caelum Biosciences, Inc. (“Caelum”), a Fortress Biotech, Inc. (NASDAQ:FBIO) Company developing treatments for rare and life-threatening diseases, today announced a complete analysis of cardiac data from Columbia University’s (“Columbia”) Phase 1b trial that supports CAEL-101’s (mAb 11-1F4) potential to improve myocardial function as […]
ST. LOUIS, June 25, 2018 (GLOBE NEWSWIRE) — Stereotaxis, Inc. (OTCQX:STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announced today that it has entered into an amendment to the long-term Development Alliance and Supply Agreement with Johnson & Johnson’s Biosense Webster, Inc. The amendment […]
Study Results Presented at American Society of Echocardiography Annual Scientific Sessions NASHVILLE, Tenn. – June 25, 2018 – Bay Labs, a medical technology company at the forefront of applying artificial intelligence (AI) to cardiovascular imaging, today announced its EchoMD AutoEF deep learning software has less variability in evaluating left ventricular […]
MENLO PARK, Calif.–(BUSINESS WIRE)–BioTrace Medical, Inc., the leader in innovative temporary pacing technology, today announced the company’s key activities at the Transcatheter Valve Therapies (TVT) structural heart disease summit, which will take place June 20-22 at the Sheraton Grand Chicago. The company’s Tempo® Temporary Pacing Lead will be featured in a […]
NEW YORK, June 18, 2018 (GLOBE NEWSWIRE) — Caelum Biosciences, Inc. (“Caelum”), a Fortress Biotech, Inc. (NASDAQ:FBIO) Company developing treatments for rare and life-threatening diseases, today announced that Columbia University (“Columbia”) will present a complete analysis of cardiac data from the Phase 1b trial of CAEL-101 (mAb 11-1F4) for the […]
CHARLOTTE, N.C., June 18, 2018 /PRNewswire/ — Milestone Pharmaceuticals USA Inc., a clinical stage cardiovascular company, today announced the launch of OutsmartPSVT.com, a new educational online resource for patients living with a recurring and sporadic heart arrhythmia called paroxysmal supraventricular tachycardia (PSVT). The website is designed to help fill a long-standing information gap in the PSVT […]
PETAH TIKVA, Israel, June 18, 2018 /PRNewswire/ — Leviticus Cardio, inventor of wireless technology for certain medical devices, announces the successful animal implantation of the world’s first Hybrid Wireless Fully Implanted Ventricular Assisted System or “Hybrid FILVAS.” The new cardio device, designed for human patients with chronic heart conditions requiring an implanted heart pump, can be […]
